Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-321,2,3
Type 10A phosphodiesterase (PDE10A) is highly expressed in the striatum, in striatonigral and striatopallidal medium-sized spiny neurons (MSNs), which express D1 and D2 dopamine receptors, respectively. PDE10A inhibitors have pharmacological and behavioral effects suggesting an antipsychotic profile...
Main Authors: | Polito, Marina, Guiot, Elvire, Gangarossa, Giuseppe, Longueville, Sophie, Doulazmi, Mohamed, Valjent, Emmanuel, Hervé, Denis, Girault, Jean-Antoine, Paupardin-Tritsch, Danièle, Castro, Liliana R. V., Vincent, Pierre |
---|---|
Format: | Online |
Language: | English |
Published: |
Society for Neuroscience
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596023/ |
Similar Items
-
The NO/cGMP pathway inhibits transient cAMP signals through the activation of PDE2 in striatal neurons
by: Polito, Marina, et al.
Published: (2013) -
DARPP-32, Jack of All Trades… Master of Which?
by: Yger, Marion, et al.
Published: (2011) -
DARPP-32 Is a Robust Integrator of Dopamine and Glutamate Signals
by: Fernandez, Éric, et al.
Published: (2006) -
BDNF–TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior
by: Besusso, Dario, et al.
Published: (2013) -
Role of the Plasticity-Associated Transcription Factor Zif268 in the Early Phase of Instrumental Learning
by: Maroteaux, Matthieu, et al.
Published: (2014)